Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. completed its transformation into Accendra Health, Inc. after selling its Products & Healthcare Services segment and the Owens & Minor brand. The remaining public company is focused on home-based care and operates through the Apria and Byram Healthcare brands.
Recurring news for the company centers on financial results, corporate name and ticker changes, material agreements, and home-based care provider relationships. Updates also cover product categories used in chronic and acute care at home, including diabetes, sleep health, respiratory care, wound care, urology and ostomy care.
Owens & Minor, Inc. (NYSE: OMI) will release its second quarter 2022 financial results before market open on August 3, 2022. A conference call for investors is scheduled for 8:00 a.m. ET the same day, providing insights into the company's performance. Owens & Minor, operating since 1882, specializes in healthcare solutions, including product manufacturing and delivery, healthcare supply, and services. With over 20,000 employees, the company focuses on enhancing supply chain efficiency and improving patient care across various settings.
Owens & Minor (NYSE: OMI) announced the election of Carissa Rollins, former CIO of Illumina, to its Board of Directors effective July 12, 2022, continuing its multi-year Board succession process. Rollins brings over 30 years of experience in enterprise technology, previously leading significant projects at UnitedHealthcare. Mark F. McGettrick has stepped down from the Board on the same date. Both the Board Chair and CEO expressed confidence that Rollins' technical skills and strategic mindset will positively influence the company's growth.
Summary not available.
Owens & Minor has commenced construction on a 350,000 sq. ft. center in Morgantown, West Virginia, set to open in late 2023. This facility will serve as a primary hub for medical supply logistics, enhancing healthcare resilience in the region. The project involves a $50 million investment and is expected to create over 100 jobs. This groundbreaking further solidifies the partnership between Owens & Minor and WVU Medicine, which aims to bolster response capabilities for public health emergencies.
Owens & Minor, Inc. (NYSE: OMI) has appointed Tammy Gomez as Executive Vice President & Chief Human Resources Officer effective July 11, 2022. Reporting to President and CEO Edward A. Pesicka, Gomez will lead the company's people strategy, focusing on talent retention, development, and engagement. She aims to enhance Owens & Minor’s culture and diversity initiatives. With over two decades of healthcare experience, including leadership roles at Cardinal Health, Gomez's appointment is expected to strengthen the company's workforce strategy.
Owens & Minor, Inc. (NYSE: OMI) announced the election of Rita Johnson-Mills and Terri Kline to its Board of Directors, effective June 1, 2022. Their extensive experience in healthcare is expected to enhance the Board's diversity and support long-term success. Johnson-Mills, with over 25 years in healthcare leadership, focuses on sustainable growth and employee engagement. Kline brings a robust background in various healthcare sectors, driving growth and M&A. Both leaders are poised to provide valuable insights for Owens & Minor's strategic direction.
Owens & Minor, Inc. (NYSE: OMI) has announced that its executive management team will present at the UBS Global Healthcare Conference on Monday, May 23rd at 11:30 AM ET. A live webcast and replay of the presentation will be available on their website in the investor relations section. With a history extending back to 1882, Owens & Minor is a global healthcare solutions company focused on product manufacturing and delivery, as well as home health supply services.
Owens & Minor, Inc. (NYSE: OMI) will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 10th at 10:00 AM PT. The chat features CEO Ed Pesicka and CFO Andy Long.
Investors can access a live webcast and replay via Owens & Minor's website. The company, headquartered in Richmond, VA, integrates healthcare solutions and has been operational since 1882, employing over 20,000 people globally.
Owens & Minor reported a strong Q1 2022 with revenue of $2.4 billion, a 3.5% increase from Q1 2021. Patient Direct segment revenue surged 25.7%, buoyed by the recent acquisition of Apria, which is expected to contribute significantly to future earnings. GAAP EPS was $0.52, while adjusted EPS reached $0.96. The company revised 2022 guidance upward, anticipating revenue between $9.9 billion and $10.3 billion and adjusted EBITDA of $580 million to $630 million, aided by $180 million from Apria. However, elective procedure volumes are projected to remain slightly below pre-pandemic levels.
Owens & Minor, Inc. (NYSE: OMI) will release its first quarter 2022 financial results after market close on May 3, 2022. A conference call for investors is scheduled for 4:30 p.m. ET the same day to discuss these results. Participants can join by calling 866-393-1604 or 1-224-357-2191 for international access. A replay will be available for one week. Owens & Minor is a global healthcare solutions provider, focusing on supply chain management and product manufacturing.